Tag Archives: covid 19
What is the Arcturus (XBB.1.16) and Its Symptoms?
What is Arcturus/XBB.1.16? Arcturus/XBB.1.16 is a mutated cousin of the SARS-CoV-2 Omicron variant and was initially identified in India in […]
ikrisuser
April 25, 2023
Arcturus- An Extremely Transmissible COVID-19 Variant Has a New Symptom
Formally known as XBB 1.16, Arcturus is a subvariant of Omicron that is causing concerns, and again the world is […]
ikrisuser
April 17, 2023
Covid 19 Cases rising again?
There is a rapid surge in the number of covid 19 patients in India as well as the World. Based on a […]
ikrisuser
April 14, 2023
Myalgia is Regarded as ‘Top’ Symptom for COVID-19 and is Now Widely Reported
Since the onset of the 2019 Novel Coronavirus Or 2019-nCoV, so many new variants of the coronavirus disease have emerged […]
ikrisuser
January 18, 2023
3.7M Treatment Courses of PAXLOVID are Planned for Delivery by Early 2023 to Help Combat COVID-19
According to Pfizer, they have reached an agreement with the U.S. Government for the purchase of an additional 3.7 Million […]
ikrisuser
January 15, 2023
New Covid-19, Omicron Variant : XBB 1.5
The new variant of SARS Covid-19 has increased global tensions among nations as the cases are increasing daily. Many Cases […]
ikrisuser
January 11, 2023
XBB.1.5- A Subvariant of Omicron is Likely to be the Next Potential Threat
The COVID outbreak continues to be a potential threat to global public health. The cases of COVID-19 have been climbing […]
ikrisuser
January 10, 2023
Kraken : Omicron variant, XBB 1.5 surge in India
We have been experiencing the fatal effects of the pandemic outbreak of Covid-19 since 2019. Over time, we developed medicines […]
ikrisuser
January 6, 2023
COVID-19 Vaccines: FDA Authorizes Moderna & Pfizer-BioNTech for Children Aged 6 Months and Above
On June 17, 2022, the US Food and Drug Administration (FDA) authorized emergency use of COVID-19 vaccines named Moderna and […]
ikrisuser
June 27, 2022
Baricitinib and casirivimab-imdevimab recommended by WHO to treat COVID-19 patients
On Friday 14’th January, the World Health Organization recommended the use of two new drugs Baricitinib and Casirivimab-Imdevimab for the […]
